Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation
Sung Woo Hong(Korea Electronics Technology Institute), Seung Kew Yoon(The Catholic University of Korea Seoul St. Mary's Hospital)
Cited by 37
Related Papers
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study
|Journal of Hepatology|2016|385
EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
|Journal for ImmunoTherapy of Cancer|2020|116
Branched-Chain Amino Acids Ameliorate Fibrosis and Suppress Tumor Growth in a Rat Model of Hepatocellular Carcinoma with Liver Cirrhosis
|PLoS ONE|2013|47
Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy
|Pharmaceutics|2021|42
Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133
|Scientific Reports|2017|39